Anavex Life Sciences
AVXL
AVXL
147 hedge funds and large institutions have $161M invested in Anavex Life Sciences in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 23
34% less capital invested
Capital invested by funds: $245M → $161M (-$83.8M)
Holders
147
Holding in Top 10
–
Calls
$7.28M
Puts
$7.19M
Top Buyers
| 1 | +$18.6M | |
| 2 | +$3.57M | |
| 3 | +$3.29M | |
| 4 |
Two Sigma Investments
New York
|
+$2.49M |
| 5 |
Citigroup
New York
|
+$2.39M |
Top Sellers
| 1 | -$2.87M | |
| 2 | -$2.86M | |
| 3 | -$2.13M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.37M |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$671K |